WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018059537) DIAZASPIRO[5.5]UNDECANE DERIVATIVE AND USE THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/059537    International Application No.:    PCT/CN2017/104286
Publication Date: 05.04.2018 International Filing Date: 29.09.2017
IPC:
C07D 519/00 (2006.01), C07D 498/10 (2006.01), A61P 11/08 (2006.01), A61P 11/06 (2006.01), A61P 11/00 (2006.01), A61K 31/425 (2006.01), A61K 31/535 (2006.01)
Applicants: SICHUAN HAISCO PHARMACEUTICAL CO., LTD. [CN/CN]; No. 136 Beverley Road, Across the Taiwan Strait Technology Industry Development Park Wenjiang District Chengdu, Sichuan 611130 (CN)
Inventors: ZHENG, Suxin; (CN).
ZHANG, Guobiao; (CN).
ZHANG, Xiaobo; (CN).
LI, Hang; (CN).
WANG, Wenjing; (CN).
DU, Yong; (CN)
Agent: BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD.; 16th Fl., Block A, Corporate Square No. 35 Jinrong Street Beijing 100033 (CN)
Priority Data:
201610867511.2 30.09.2016 CN
Title (EN) DIAZASPIRO[5.5]UNDECANE DERIVATIVE AND USE THEREOF
(FR) DÉRIVÉ DE DIAZASPIRO [5,5] UNDÉCANE ET SON UTILISATION
(ZH) 一种二氮杂螺[5.5]十一碳烷衍生物及其用途
Abstract: front page image
(EN)The present invention relates to a diazaspiro[5.5]undecane derivative and a use thereof. The derivative is a compound represented by general formula (I) or a stereoisomer, hydrate, metabolite, solvate, pharmaceutically acceptable salt, eutectic crystal, or prodrug thereof. The present invention also relates to a preparation method of the derivative and an application of the same in preparing a drug for treating an obstructive airway disease. The definition of each substituent is consistent with the definition in the specification.
(FR)La présente invention concerne un dérivé de diazaspiro [5,5] undécane et son utilisation. Le dérivé est un composé représenté par la formule générale (I) ou un stéréoisomère, un hydrate, un métabolite, un solvate, un sel pharmaceutiquement acceptable, un cristal eutectique ou un promédicament de celui-ci. La présente invention concerne également un procédé de préparation du dérivé et une application de celui-ci dans la préparation d'un médicament pour le traitement d'une maladie respiratoire obstructive. La définition de chaque substituant est cohérente avec la définition dans la spécification.
(ZH)本发明涉及一种二氮杂螺[5.5]十一碳烷衍生物及其用途,该衍生物如通式(I)所示的化合物或其立体异构体、水合物、代谢产物、溶剂化物、药学上可接受的盐、共晶或前药,本发明还涉及所述衍生物的制备方法和在制备用于治疗气道阻塞性疾病药物中的应用,其中,各取代基的定义与说明书中一致。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)